Full Florian, Jungnickl Doris, Reuter Nina, Bogner Elke, Brulois Kevin, Scholz Brigitte, Stürzl Michael, Myoung Jinjong, Jung Jae U, Stamminger Thomas, Ensser Armin
Institute for Clinical and Molecular Virology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Erlangen, Germany.
Institut für Medizinische Virologie, Charité-Universitätsmedizin Berlin, Berlin, Germany.
PLoS Pathog. 2014 Jan;10(1):e1003863. doi: 10.1371/journal.ppat.1003863. Epub 2014 Jan 16.
Nuclear domain 10 (ND10) components are restriction factors that inhibit herpesviral replication. Effector proteins of different herpesviruses can antagonize this restriction by a variety of strategies, including degradation or relocalization of ND10 proteins. We investigated the interplay of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) infection and cellular defense by nuclear domain 10 (ND10) components. Knock-down experiments in primary human cells show that KSHV-infection is restricted by the ND10 components PML and Sp100, but not by ATRX. After KSHV infection, ATRX is efficiently depleted and Daxx is dispersed from ND10, indicating that these two ND10 components can be antagonized by KSHV. We then identified the ORF75 tegument protein of KSHV as the viral factor that induces the disappearance of ATRX and relocalization of Daxx. ORF75 belongs to a viral protein family (viral FGARATs) that has homologous proteins in all gamma-herpesviruses. Isolated expression of ORF75 in primary cells induces a relocalization of PML and dispersal of Sp100, indicating that this viral effector protein is able to influence multiple ND10 components. Moreover, by constructing a KSHV mutant harboring a stop codon at the beginning of ORF75, we could demonstrate that ORF75 is absolutely essential for viral replication and the initiation of viral immediate-early gene expression. Using recombinant viruses either carrying Flag- or YFP-tagged variants of ORF75, we could further corroborate the role of ORF75 in the antagonization of ND10-mediated intrinsic immunity, and show that it is independent of the PML antagonist vIRF3. Members of the viral FGARAT family target different ND10 components, suggesting that the ND10 targets of viral FGARAT proteins have diversified during evolution. We assume that overcoming ND10 intrinsic defense constitutes a critical event in the replication of all herpesviruses; on the other hand, restriction of herpesviral replication by ND10 components may also promote latency as the default outcome of infection.
核域10(ND10)成分是抑制疱疹病毒复制的限制因子。不同疱疹病毒的效应蛋白可通过多种策略对抗这种限制,包括降解或重新定位ND10蛋白。我们研究了卡波西肉瘤相关疱疹病毒(KSHV)感染与核域10(ND10)成分介导的细胞防御之间的相互作用。在原代人细胞中进行的敲低实验表明,KSHV感染受到ND10成分PML和Sp100的限制,但不受ATRX的限制。KSHV感染后,ATRX被有效消耗,Daxx从ND10中分散,表明这两种ND10成分可被KSHV对抗。然后我们鉴定出KSHV的ORF75被膜蛋白是诱导ATRX消失和Daxx重新定位的病毒因子。ORF75属于一个病毒蛋白家族(病毒FGARATs),在所有γ-疱疹病毒中都有同源蛋白。在原代细胞中单独表达ORF75会诱导PML重新定位和Sp100分散,表明这种病毒效应蛋白能够影响多种ND10成分。此外,通过构建在ORF75起始处带有终止密码子的KSHV突变体,我们可以证明ORF75对于病毒复制和病毒立即早期基因表达的起始绝对必要。使用携带ORF75的Flag或YFP标签变体的重组病毒,我们可以进一步证实ORF75在对抗ND10介导的固有免疫中的作用,并表明它独立于PML拮抗剂vIRF3。病毒FGARAT家族的成员靶向不同的ND10成分,表明病毒FGARAT蛋白的ND10靶点在进化过程中已经多样化。我们假设克服ND10固有防御是所有疱疹病毒复制中的关键事件;另一方面,ND10成分对疱疹病毒复制的限制也可能促进潜伏感染作为感染的默认结果。